Mirabella Financial Services LLP Regeneron Pharmaceuticals, Inc. Transaction History

Mirabella Financial Services LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$883.2 - $1071.19 $842,572 - $1.02 Million	954 Added 311.76%	1,260 $1.32 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $276,223 - $303,965	306 New	306 $294,000
Q2 2023 Aug 07, 2023	BUY	$700.03 - $830.35 $364,715 - $432,612	521 New	521 $374,000
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $1.44 Million - $1.94 Million	-2,627 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$595.12 - $698.43 $1.56 Million - $1.83 Million	2,627 New	2,627 $1.84 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $2.54 Million - $3.13 Million	-4,671 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $2.68 Million - $3.18 Million	4,671 New	4,671 $2.83 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.